Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.71 CAD | -1.16% | -3.93% | -20.09% |
Sales 2024 * | 120M 87.68M | Sales 2025 * | 135M 98.88M | Capitalization | 78.63M 57.66M |
---|---|---|---|---|---|
Net income 2024 * | - 0 | Net income 2025 * | 11M 8.07M | EV / Sales 2024 * | 0.66 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.58 x |
P/E ratio 2024 * |
-5,182
x | P/E ratio 2025 * |
8.63
x | Employees | 103 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.58% |
Latest transcript on Theratechnologies Inc.
1 day | -1.16% | ||
1 week | -3.93% | ||
1 month | -3.39% | ||
3 months | -14.93% | ||
6 months | -20.47% | ||
Current year | -20.09% |
Managers | Title | Age | Since |
---|---|---|---|
Paul Lévesque
CEO | Chief Executive Officer | 60 | 20-04-05 |
Philippe Dubuc
DFI | Director of Finance/CFO | 57 | 16-02-23 |
Chief Tech/Sci/R&D Officer | 61 | 06-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Andrew Molson
BRD | Director/Board Member | 56 | 20-10-15 |
Frank Holler
CHM | Chairman | 67 | 21-06-22 |
Director/Board Member | 68 | 17-05-15 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 1.71 | -1.16% | 1,400 |
24-05-30 | 1.73 | -.--% | 8,200 |
24-05-29 | 1.73 | -1.14% | 24,199 |
24-05-28 | 1.75 | -1.13% | 6,785 |
24-05-27 | 1.77 | -0.56% | 2,730 |
Delayed Quote Toronto S.E., May 31, 2024 at 03:59 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.09% | 57.63M | |
-2.29% | 89.87B | |
-3.95% | 37.57B | |
-13.07% | 32.75B | |
+63.05% | 26.47B | |
-22.14% | 14.25B | |
-7.96% | 12.99B | |
-9.33% | 11.93B | |
-46.33% | 10.84B | |
+5.77% | 9.11B |
- Stock Market
- Equities
- TH Stock